Lowest entry price · Provider review
Embody GLP-1 weight loss review: $69 is a discount, not a price
$69 a month for compounded semaglutide is the cheapest entry rate in this vertical, and Embody is straightforward about where it came from: the same product is listed at $299. Everything that matters about this platform sits in the gap between those two numbers.
Published · Rates as published by Embody on that date · Editorial score 7.6 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
A GLP-1 course is not a purchase, it is a subscription with a clinical reason to keep going. So the number that decides whether a program is affordable is the twelve-month one, and Embody publishes two rates that produce wildly different twelve-month numbers for the identical medication.
At $69 a month, a year of compounded semaglutide is $828. At the $299 list rate it is $3,588. That is a $2,760 spread on the same molecule from the same platform, decided entirely by whether the offer is still running when your card is charged.
The short answer
- Best case
- $69 holds for twelve months. $828 a year, free shipping included, no membership and no contract — the cheapest credible route to compounded semaglutide we have priced.
- The risk
- The offer lapses at month six. Six months at $69 then six at $299 is $2,208 — more than double the promo-rate year, and above several platforms that never advertised a headline this low.
- The upgrade
- Tirzepatide at $119. $1,428 a year, $600 more than semaglutide, for the dual-agonist molecule rather than a bigger service.
What Embody costs over three, six and twelve months
The table multiplies out the published rates and assumes nothing else — no dose escalation, no add-ons, no change to the offer. Read the middle row as the downside case rather than a quote: it is what the same treatment costs if the promotion is not running when you renew.
| Rate | Per month | 3 months | 6 months | 12 months |
|---|---|---|---|---|
| Compounded semaglutide (promo) | $69 | $207 | $414 | $828 |
| Compounded semaglutide (pre-promo list) | $299 | $897 | $1,794 | $3,588 |
| Compounded tirzepatide | $119 | $357 | $714 | $1,428 |
The row that is easiest to skip is the most useful one. Nearly every platform in this category discounts the first month and prices the rest higher — RxActivate and Start Willow both do a version of it. What is unusual about Embody is the size of the step: $230 a month rather than the $50 to $100 that is typical.
The $119 tier is a different drug, not a better plan
Most price ladders in telehealth sell the same medication with more service bolted on at each rung. Embody’s does not. The step from $69 to $119 changes the active ingredient from semaglutide, a single-receptor GLP-1 agonist, to tirzepatide, which acts at both the GLP-1 and GIP receptors. The support, the shipping and the intake are the same on both.
That makes the $600 annual premium a clinical decision rather than a budgeting one. The published comparative research on these two molecules has generally favoured tirzepatide on weight change, but tolerability and history differ per patient, and the person qualified to weigh that is the clinician reviewing your intake.
Both tiers are compounded preparations. Neither is Ozempic, Wegovy or Zepbound, and Embody does not claim otherwise — but if what you actually need is the FDA-approved branded product, this platform is not a cheaper route to it, it is a different product.
What the $69 does and does not buy
Embody runs a deliberately thin model: online intake, licensed clinician review usually inside 24 hours, compounded medication filled at a licensed pharmacy, free delivery in one to two days, 24/7 access for dosing and side-effect questions. No membership fee, no minimum term, cancel without penalty.
What is missing is everything a full weight-management program contains — coaching, structured nutrition support, body-composition monitoring. That absence is the reason the price works, and it is also the reason the price is not directly comparable to platforms charging three times as much. The National Institute of Diabetes and Digestive and Kidney Diseases notes these medications work best alongside a lifestyle program and that regain is likely once treatment stops without sustained changes — with Embody, sourcing that program is your job.
What Embody does well
- $69 a month is the lowest published semaglutide rate in this vertical
- Tirzepatide available at $119 without changing platforms
- No membership fee and no minimum term — the headline rate is close to all-in
- Free shipping, typically one to two days after approval
- Clinician review usually completed within 24 hours
- 24/7 support access for dosing and side-effect questions
- Honest about the pre-promotional list price rather than hiding it
Where it falls short
- The $69 rate is explicitly a limited-time offer against $299
- Compounded only — no branded Ozempic, Wegovy or Zepbound
- Final pricing may vary with dose; the maintenance-dose rate is unpublished
- No coaching, nutrition curriculum or advanced monitoring included
- Direct-pay only, so nothing is recoverable through insurance
- Renewal terms are not published alongside the promotional rate
How the program runs
Three steps, and the timings are the part worth noting rather than the structure. Embody quotes a clinician decision inside roughly a day and delivery one to two days after that, which puts a realistic start at under a week from intake.
- Complete the online intake — health history, goals, current medications
- A licensed clinician reviews eligibility, typically within 24 hours
- On approval, compounded medication ships free and arrives in one to two days
- Dosing and side-effect questions go through 24/7 support for as long as you stay enrolled
Who it suits
Someone who has already decided they want compounded semaglutide, does not need a program wrapped around it, and is optimising the monthly number. On that brief nothing in the vertical beats $69. Compare it against the flat-rate platforms rather than the promotional ones — the honest benchmark is a provider whose month-13 price is the same as its month-one price.
It suits someone with a low tolerance for price risk considerably less well. If a jump to $299 would end your course mid-titration, a platform with a duller headline and a published renewal rate — the term pricing at bmiMD, for example, or the flat tiers at FeelGood Meds — is a safer purchase even at a higher month-one cost.
The verdict
Embody is priced at the floor of the category and structured cleanly around it: no membership, no contract, free fast shipping, both molecules on one intake. At $828 a year the semaglutide tier is genuinely the cheapest credible option we have priced, and the $119 tirzepatide rate is competitive on its own terms.
The weakness is not the service, it is the durability of the number. A 77% discount against a published list price is an offer with an end date somewhere, and Embody does not say where. Neither does it publish what the maintenance dose costs, which is the other way a cheap GLP-1 becomes an expensive one.
Worth starting if you get two things in writing first: the rate that applies at renewal, and the rate that applies at your maintenance dose. With those confirmed, this is the strongest entry price in the vertical. Without them, $69 is a headline rather than a budget.
Embody: common questions
How much does Embody cost?
Compounded semaglutide is $69 a month, cut from a list price of $299, and compounded tirzepatide is $119 a month. Both include free shipping and carry no long-term commitment. At $69, twelve months of semaglutide is $828; at the $299 list rate the same year is $3,588.
Is the $69 Embody price permanent?
Embody presents it as a limited-time offer against a $299 list price, so treat it as promotional rather than fixed. That matters more here than on most platforms because the discount is 77% — the gap between the promotional and list rate is $230 a month, or $2,760 over a year. Get the renewal rate confirmed in writing before you enrol.
Is Embody tirzepatide worth $50 more a month than semaglutide?
The premium is $600 over a year. Tirzepatide acts on two incretin receptors rather than one, and head-to-head research has generally favoured it on weight change, so the $50 buys a different molecule rather than a service upgrade. Whether that is worth it is a clinical question for the prescribing clinician, not a pricing one.
Is Embody FDA-approved?
No. Embody dispenses compounded semaglutide and tirzepatide, which are prepared by licensed compounding pharmacies and are not FDA-approved finished drug products. The active ingredients are the same molecules found in Ozempic, Wegovy and Zepbound, but the finished preparation has not been through FDA review.
Does Embody take insurance?
No. It is a direct-pay platform, which is standard for compounded GLP-1 programs — insurers rarely reimburse compounded preparations regardless of the provider. The upside is that there is no prior-authorisation process to fail; the downside is that every dollar is out of pocket.
How fast does Embody ship?
Embody advertises free shipping arriving one to two days after clinician approval, with the clinical review itself typically completed within 24 hours. That is at the fast end of the category, though it is a commitment on the platform side rather than a guarantee you can enforce.
Is there a membership fee or contract?
No membership fee and no minimum term — Embody states you can cancel without penalty. That makes the advertised monthly rate close to the all-in rate, which is not true of every platform quoting a similar headline number.
What does Embody not include?
The lean price buys medication, clinician review and support. There is no integrated coaching program, no structured nutrition curriculum and no advanced monitoring of the kind higher-priced platforms bundle in. If a program rather than a prescription is what you want, the $69 is not the right comparison to be making.
What happens to the price when my dose increases?
Embody states final pricing may vary based on dose and clinician recommendation, which is the standard escalation caveat in this category. Dose escalation is the usual reason a cheap GLP-1 stops being cheap, so ask what the maintenance dose costs before you treat $69 as your ongoing number.
Keep comparing
See how the rest of the market prices the same treatment on the weight loss rankings, or read the head-to-head articles in the comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what Embody published on the date above and changes frequently. The $69 semaglutide rate is advertised as a limited-time offer against a $299 list price, and final pricing may vary by dose and clinician recommendation. Term totals are calculated from the published monthly rates and assume no dose escalation.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody, and does not sell treatment. Read our ranking methodology.